Thompson Davis & Co., Inc. Kezar Life Sciences, Inc. Transaction History

Thompson Davis & Co., Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$7.44 - $16.72 $2,232 - $5,016	-300 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$15.5 - $21.41 $11,237 - $15,522	-725 Reduced 70.73%	300 $6,000
Q2 2018 Aug 03, 2018	BUY	$17.15 - $17.79 $17,578 - $18,234	1,025 New	1,025 $18,000

39.6M

3.2K

700

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $509M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

Get notified when there are updates to the investment portfolio of Thompson Davis & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on Thompson Davis & Co., Inc. with notifications on news.